Who owns Diamedica Therapeutics Inc?
- Ticker: DMAC
- CUSIP Number: 25253x207
Tip: Access positions for across all investors
Analyze quarterly positions in Diamedica Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Diamedica Therapeutics stock
Who bought or sold Diamedica Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 1.0M | $3.0M | 0% | Jun 2024 |
|
| First Manhattan | 839k | $2.5M | -1% | Jun 2024 |
|
| Paragon Associates & Paragon Associates Ii Joint Venture | 483k | $1.4M | -3% | Jun 2024 |
|
| Bleichroeder | 382k | $1.6M | 0% | Sep 2024 |
|
| Geode Capital Management | 307k | $1.3M | 30% | Sep 2024 |
|
| LPL Financial | 141k | $589k | 703% | Sep 2024 |
|
| Northern Trust | 120k | $504k | -6% | Sep 2024 |
|
| BlackRock | 108k | $452k | 100% | Sep 2024 |
|
| BlackRock | 105k | $311k | 2% | Jun 2024 |
|
| Susquehanna International | 102k | $425k | 134% | Sep 2024 |
|
| Morgan Stanley | 86k | $254k | -6% | Jun 2024 |
|
| State Street Corporation | 69k | $203k | 3% | Jun 2024 |
|
| Ronald Blue Trust | 44k | $131k | 100% | Sep 2024 |
|
| Catalyst Financial Partners | 39k | $161k | 0% | Sep 2024 |
|
| Citigroup | 22k | $93k | 100% | Sep 2024 |
|
| Citadel Advisors | 20k | $85k | 89% | Sep 2024 |
|
| Stonebridge Capital Advisors | 18k | $73k | -12% | Sep 2024 |
|
| Dimensional Fund Advisors | 17k | $71k | 0% | Sep 2024 |
|
| Bnp Paribas Arbitrage, Snc | 17k | $69k | 9% | Sep 2024 |
|
| Charles Schwab Investment Management | 13k | $56k | 0% | Sep 2024 |
|
| Raymond James Financial Services Advisors | 12k | $48k | 100% | Sep 2024 |
|
| Magnolia Capital Advisors | 10k | $42k | 0% | Sep 2024 |
|
| Point72 Asia | 9.5k | $40k | 100% | Sep 2024 |
|
| Massmutual Trust | 4.8k | $20k | 0% | Sep 2024 |
|
| Us Bancorp | 4.3k | $18k | 0% | Sep 2024 |
|
| Simplex Trading | 3.7k | $15k | 100% | Sep 2024 |
|
| Cubist Systematic Strategies | 3.3k | $14k | 100% | Sep 2024 |
|
| Naples Money Management | 2.1k | $8.7k | -31% | Sep 2024 |
|
| Tower Research Capital | 1.9k | $5.6k | -30% | Jun 2024 |
|
| TD Waterhouse Canada | 1.1k | $4.4k | 0% | Sep 2024 |
|
| Advisor Group Holdings | 1.1k | $4.4k | 6% | Sep 2024 |
|
| Legend Financial Advisors | 1.0k | $4.2k | 0% | Sep 2024 |
|
| Royal Bank of Canada | 805.00 | $3.2k | -24% | Sep 2024 |
|
| Bank of America Corporation | 213.00 | $892.001400 | 16% | Sep 2024 |
|
| Cornerstone Planning Group | 80.00 | $346.000000 | 100% | Sep 2024 |
|
| Jpmorgan Chase & Co | 27.00 | $113.000400 | 100% | Sep 2024 |
|
Who sold out of Diamedica Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Aristides Capital | Jun 2024 | 106k | $314k |
| Jane Street | Jun 2024 | 15k | $45k |
| Federation des caisses Desjardins du Quebec | Jun 2024 | 230.00 | $679.006000 |